BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20660715)

  • 1. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1.
    Hwang MK; Bode AM; Byun S; Song NR; Lee HJ; Lee KW; Dong Z
    Cancer Res; 2010 Sep; 70(17):6859-69. PubMed ID: 20660715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.
    Li S; Bode AM; Zhu F; Liu K; Zhang J; Kim MO; Reddy K; Zykova T; Ma WY; Carper AL; Langfald AK; Dong Z
    Carcinogenesis; 2011 May; 32(5):779-85. PubMed ID: 21349818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-promoting effect of capsaicin on DMBA/TPA-induced skin tumorigenesis by modulating inflammation, Erk and p38 in mice.
    Liu Z; Zhu P; Tao Y; Shen C; Wang S; Zhao L; Wu H; Fan F; Lin C; Chen C; Zhu Z; Wei Z; Sun L; Liu Y; Wang A; Lu Y
    Food Chem Toxicol; 2015 Jul; 81():1-8. PubMed ID: 25846502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.
    Bode AM; Cho YY; Zheng D; Zhu F; Ericson ME; Ma WY; Yao K; Dong Z
    Cancer Res; 2009 Feb; 69(3):905-13. PubMed ID: 19155296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
    Shrotriya S; Kundu JK; Na HK; Surh YJ
    Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment.
    Park M; Naidoo AA; Burns A; Choi JK; Gatfield KM; Vidgeon-Hart M; Bae IH; Lee CS; Choi G; Powell AJ; Park YH; Fagg R
    Cell Biol Toxicol; 2018 Apr; 34(2):143-162. PubMed ID: 28815372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.
    Sharma SD; Meeran SM; Katiyar N; Tisdale GB; Yusuf N; Xu H; Elmets CA; Katiyar SK
    Carcinogenesis; 2009 Nov; 30(11):1970-7. PubMed ID: 19759192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Elemene inhibits 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin tumorigenesis through suppression of NF-κB-associated signaling events in the mouse skin model.
    Hu X; Wang L; Zhang L; Zhang T
    J Biochem Mol Toxicol; 2020 Oct; 34(10):e22550. PubMed ID: 32662567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TRPV1 antagonist, PAC-14028 does not increase the risk of tumorigenesis in chemically induced mouse skin carcinogenesis.
    Choi JK; Cho W; Lee JH; Choi G; Park M
    Regul Toxicol Pharmacol; 2020 Apr; 112():104613. PubMed ID: 32044384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
    Sharma M; Mohapatra J; Argade A; Deshpande SS; Shah GB; Chatterjee A; Jain MR
    Immunopharmacol Immunotoxicol; 2014 Aug; 36(4):282-9. PubMed ID: 24946851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
    Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
    Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ; Pavone A; Rupp T; Cantu AR
    Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.
    Yang H; Wang Z; Capó-Aponte JE; Zhang F; Pan Z; Reinach PS
    Exp Eye Res; 2010 Sep; 91(3):462-71. PubMed ID: 20619260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
    Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H
    Int J Cancer; 2005 Jan; 113(3):423-33. PubMed ID: 15455341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development.
    Chun KS; Lao HC; Trempus CS; Okada M; Langenbach R
    Carcinogenesis; 2009 Sep; 30(9):1620-7. PubMed ID: 19587094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
    Goerttler K; Löhrke H; Hesse B
    Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
    Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
    Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
    Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
    Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.